Bellicum Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €1.28M -75.8% -€21.30M +160.7% -1,664.9% -15 pp -€21.97M +11.5% -1,717.5% -13 pp
    €5.29M +1,140.0% -€8.17M +11.1% -154.5% +16 pp -€19.70M -58.8% -372.6% +110 pp
    €426.48K -93.0% -€7.35M -93.2% -1,723.8% +0.41 pp -€47.79M -27.3% -11,205.0% -100 pp
    €6.09M +537.8% -€107.55M +28.6% -1,765.3% +70 pp -€65.72M +5.3% -1,078.6% +55 pp
    €955.31K +505.4% -€83.62M +6.8% -8,753.2% +410 pp -€62.41M +20.2% -6,532.6% +260 pp
    €157.80K -52.3% -€78.28M +32.6% -49,610.3% -320 pp -€51.90M +40.8% -32,891.9% -220 pp
    €330.95K +37.6% -€59.06M +42.6% -17,845.6% -6.3 pp -€36.87M +42.6% -11,139.4% -3.9 pp
    €240.53K -84.2% -€41.41M -42.2% -17,215.6% -120 pp -€25.85M -46.4% -10,746.5% -76 pp
    €1.52M -8.3% -€71.62M +953.7% -4,717.1% -43 pp -€48.19M +679.8% -3,174.4% -28 pp
    €1.66M +32.0% -€6.80M +27.2% -410.6% +0.15 pp -€6.18M +27.2% -373.4% +0.14 pp
    €1.25M -€5.34M -426.0% -€4.86M -387.4%

    Notifications